Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment

Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment

Immunotherapy represents a groundbreaking therapeutic approach, based on the immune system’s intrinsic capacity to interfere with tumor progression, that opens the horizons in the treatment of endometrial cancer. However, the clinical efficacy of immunotherapy is hampered by the development of resis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liubov A. Tashireva, Irina V. Larionova, Nikita A. Ermak, Anastasia A. Maltseva, Ekaterina I. Livanos, Anna Yu. Kalinchuk, Marina N. Stakheyeva, Larisa A. Kolomiets
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	endometrial cancer immunotherapy immune checkpoint inhibitors tumor microenvironment predictive biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1523518/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer
by: Jenny Ling-Yu Chen, et al.
Published: (2024-11-01)

Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
by: Li-Chun Lu, et al.
Published: (2023-04-01)

Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion?
by: Musen Wang, et al.
Published: (2025-02-01)

Prevalence of occult endometrial carcinoma in patients with endometrial intraepithelial neoplasia who underwent hysterectomy
by: Waraphon Thongsang, et al.
Published: (2025-01-01)

Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma
by: Fushan Gao, et al.
Published: (2024-12-01)

To do or not to do? – Endometrial biopsy in younger women with abnormal uterine bleeding
by: Sandra Lynn Jaya-Bodestyne, et al.
Published: (2025-03-01)

Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
by: Bujnak AC, et al.
Published: (2025-01-01)

Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer
by: Haruka Suzuki, et al.
Published: (2025-02-01)

Immunotherapy of osteosarcoma based on immune microenvironment modulation
by: Heping Lian, et al.
Published: (2025-01-01)

Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
by: Yiming Liu, et al.
Published: (2025-02-01)

Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
by: Ji Ren, et al.
Published: (2025-01-01)

Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy
by: Jian Huang, et al.
Published: (2025-01-01)

Models for predicting risk of endometrial cancer: a systematic review
by: Bea Harris Forder, et al.
Published: (2025-02-01)

The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)

Treatment of uterine fibroid: focus on endometrial receptivity. A pilot randomized prospective study
by: Yulia E. Dobrokhotova, et al.
Published: (2024-12-01)

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01)

The Effect of Autologous Platelet Rich Plasma on Endometrial Receptivity: A Narrative Review
by: Milan Stefanović, et al.
Published: (2025-01-01)

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
by: Vakkas Korkmaz, et al.
Published: (2013-08-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)

Endometrial Receptivity–Lessons from “Omics”
by: Louie Ye, et al.
Published: (2025-01-01)

Comparing the efficacy of different methods in assessing cervical stromal invasion in endometrial carcinoma: a retrospective study of 2,020 patients
by: Ying Yang, et al.
Published: (2025-02-01)

Rapamycin inhibits tamoxifen-induced endometrial proliferation in vitro as a pilot approach for endometrial protection in breast cancer
by: Akiko Nakamura, et al.
Published: (2025-01-01)

The Effect of Endometrial Compaction During the Luteal Phase on Pregnancy Outcomes in Patients Undergoing Intrauterine Insemination
by: Fulya Cagli, et al.
Published: (2023-03-01)

Outcomes of endometrial cancer prevention strategies in patients with Lynch syndrome: a nationwide cohort study in the NetherlandsResearch in context
by: Ellis L. Eikenboom, et al.
Published: (2025-01-01)

The Effect of Age on Clinical and Laboratory Parameters in Reproductive Age Women with Endometrial Polyps
by: Aytekin Tokmak, et al.
Published: (2014-12-01)

Laparoscopic Sentinel Node Mapping with Surgical Staging following Hysteroscopic Endometrial Resection in Endometrial Stromal Sarcoma
by: Phornsawan Wasinghon, et al.
Published: (2020-08-01)

Oxidative Stress in Endometrial Flushing Fluid of Patients with Polycystic Ovary Syndrome, Endometrioma and Uterine Leiomyoma: Comparison with Healthy Controls
by: Mustafa Demir, et al.
Published: (2020-08-01)

Comparison of Endometrial Microbiota Results Between Patients with Unexplained Infertility and Fertile Patients through 16s rRNA Sequencing
by: Gonca Ozten Dere, et al.
Published: (2023-12-01)

Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer
by: Biying Wang, et al.
Published: (2025-01-01)

Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
by: Tangyi Wang, et al.
Published: (2025-01-01)

TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
by: Juntao Qi, et al.
Published: (2025-02-01)

Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study
by: Lin Cheng Han, et al.
Published: (2024-12-01)

Comparison of Frozen and Final Pathology Results in Patients Operated for Endometrial Hyperplasia
by: Gonca Turker Ergun, et al.
Published: (2024-12-01)

Endometrial Carcinoma Presenting with an Isolated Osseous Metastasis: A Case Report
by: Nesrine Tounsi, et al.
Published: (2022-03-01)

Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer
by: Tobias Max Philipp Hartwich, et al.
Published: (2024-09-01)

Quercetin inhibits the biological activity of endometrial cancer by regulating autophagy: A network pharmacology analysis and cellular experimental validation
by: Lingchen Yang, et al.
Published: (2025-02-01)

Cost-effectiveness analysis of durvalumab with chemotherapy and maintenance durvalumab with or without olaparib for advanced endometrial cancer
by: Jiahao Zhang, et al.
Published: (2025-01-01)

Clinical analysis of molecular typing of 146 cases of endometrial carcinoma
by: Bo Zhang, et al.
Published: (2025-01-01)

Embryo versus endometrial receptivity: untangling a complex debate
by: Ramazan Mercan, et al.
Published: (2025-01-01)

Hemoglobin A1c Level is Associated with Lymphovascular Space Invasion in Diabetic Endometrial Cancer Patients
by: Ayse Rabia Senkaya, et al.
Published: (2024-04-01)